Cite
HARVARD Citation
Preda, C. et al. (2019). Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy. United European Gastroenterology journal. 7 (5), pp. 699-708. [Online].